.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Mallinckrodt
Covington
Chubb
Accenture
Medtronic
Citi
Argus Health
Moodys

Generated: December 15, 2017

DrugPatentWatch Database Preview

Fresenius Kabi Oncol Company Profile

« Back to Dashboard

What is the competitive landscape for FRESENIUS KABI ONCOL, and what generic and branded alternatives to FRESENIUS KABI ONCOL drugs are available?

FRESENIUS KABI ONCOL has twelve approved drugs.



Summary for Fresenius Kabi Oncol

US Patents:0
Tradenames:11
Ingredients:11
NDAs:12
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi OncolCARBOPLATINcarboplatinINJECTABLE;IV (INFUSION)077432-001Sep 29, 2006APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolCARBOPLATINcarboplatinINJECTABLE;IV (INFUSION)077432-003Sep 29, 2006APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolPACLITAXELpaclitaxelINJECTABLE;INJECTION077574-001Nov 27, 2006APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolMITOXANTRONE HYDROCHLORIDEmitoxantrone hydrochlorideINJECTABLE;INJECTION078606-001May 14, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION065411-001Aug 20, 2007APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolOXALIPLATINoxaliplatinINJECTABLE;IV (INFUSION)078810-001Aug 7, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolOXALIPLATINoxaliplatinINJECTABLE;IV (INFUSION)078811-001Jun 10, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolMITOXANTRONE HYDROCHLORIDEmitoxantrone hydrochlorideINJECTABLE;INJECTION078606-003May 14, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolOXALIPLATINoxaliplatinINJECTABLE;IV (INFUSION)078810-002Aug 7, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi OncolCARBOPLATINcarboplatinINJECTABLE;IV (INFUSION)077432-002Sep 29, 2006APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Cipla
Chinese Patent Office
Covington
Teva
Julphar
Cerilliant
UBS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot